These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9516375)

  • 21. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transderm Scop patches for prevention of motion sickness.
    Johnson P; Hansen D; Matarazzo D; Petterson L; Swisher C; Trappolini A
    N Engl J Med; 1984 Aug; 311(7):468-9. PubMed ID: 6749195
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing motion sickness.
    Hodgson T
    Can Med Assoc J; 1982 Jun; 126(12):1374. PubMed ID: 7083089
    [No Abstract]   [Full Text] [Related]  

  • 24. The pharmacologic absis for the control of motion sickness by drugs.
    Brand J
    Pharmacol Physicians; 1968 Mar; 2(3):1-5. PubMed ID: 4384429
    [No Abstract]   [Full Text] [Related]  

  • 25. Transdermal scopolamine for motion sickness.
    Med Lett Drugs Ther; 1981 Oct; 23(21):89-90. PubMed ID: 7027000
    [No Abstract]   [Full Text] [Related]  

  • 26. Seasickness in totally-enclosed motor-propelled survival craft: remedial measures.
    Landolt JP; Monaco C
    Aviat Space Environ Med; 1992 Mar; 63(3):219-25. PubMed ID: 1567325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed dilated pupil in the long distance traveller.
    Dunlop IS
    Med J Aust; 1995 Jan; 162(1):56. PubMed ID: 7845307
    [No Abstract]   [Full Text] [Related]  

  • 28. [Motion sickness--causes, symptoms, therapy].
    von Baumgarten R; Reiser M
    Verh Dtsch Ges Inn Med; 1989; 95():593-7. PubMed ID: 2690530
    [No Abstract]   [Full Text] [Related]  

  • 29. The Republic of Singapore Navy's Scopoderm TTS study: results after 2,200 man-days at sea.
    How J; Lee PS; Seet LC; Tan PK
    Aviat Space Environ Med; 1988 Jul; 59(7):646-50. PubMed ID: 3044323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative efficacy of the proposed Space Shuttle antimotion sickness medications.
    Hordinsky JR; Schwartz E; Beier J; Martin J; Aust G
    Acta Astronaut; 1982; 9(6-7):375-83. PubMed ID: 11541691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 32. Transdermal hyoscine induced unilateral mydriasis.
    Hannon B; Jennings V; Twomey M; O'Reilly M
    BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
    Harnett MJ; O'Rourke N; Walsh M; Carabuena JM; Segal S
    Anesth Analg; 2007 Sep; 105(3):764-9. PubMed ID: 17717237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal scopolamine-induced psychosis.
    Ziskind AA
    Postgrad Med; 1988 Sep; 84(3):73-6. PubMed ID: 2901077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine.
    Boyd JL; Du B; Vaksman Z; Locke JP; Putcha L
    J Gravit Physiol; 2007 Jul; 14(1):P107-8. PubMed ID: 18372722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
    Pingree BJ; Pethybridge RJ
    Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of the preparation Gavinton in preventing motion sickness].
    Bodo D; Kotovskaia AR; Galle RR; Gavrilova LN; Gusakova GA
    Kosm Biol Aviakosm Med; 1982; 16(3):49-51. PubMed ID: 7098411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations of transdermal scopolamine addiction.
    Luetje CM; Wooten J
    Ear Nose Throat J; 1996 Apr; 75(4):210-4. PubMed ID: 8935644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of scopolamine and cyclizine on visual-vestibular interaction in humans.
    Gowans J; Matheson A; Darlington CL; Smith PF
    J Vestib Res; 2000; 10(2):87-92. PubMed ID: 10939683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.